Acceleron Pharma (United States)

Recent papers from Acceleron Pharma (United States)

1. Liquid Compared to Solid Oral Formulations of the Thyroid Hormone Receptor Agonist Elunetirom Under Fasted and Fed Conditions in Healthy ParticipantsClinical and Translational Science · 2026
2. Design and Commissioning of a Deuterium-Tritium Gas Delivery System for Muon-Catalyzed Fusion in a Diamond Anvil CellFusion Science & Technology · 2026
3. The MuFusE large-volume diamond anvil cell for exploring muon-catalyzed fusion at higher pressures and temperaturesReview of Scientific Instruments · 2026
4. Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating PeptidesInternational Journal of Molecular Sciences · 2026
5. Oral 18-methoxycoronaridine activity in simian and murine Leishmania amazonensis infectionFrontiers in Pharmacology · 2026
6. ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus)PLoS ONE · 2026
7. Компарација Традиционалне Кредитне Анализе И Доношења Одлука У Кредитном Пословању Са Физичким Лицима Заснованог На Скоринг СиситемимаНОВИ ЕКОНОМИСТ · 2015
8. Mechanistic insights into postoperative delirium using untargeted high-throughput proteomics in elderly patients - a case-control studyScientific Reports · 2026
9. Rapid purification of brain protein complexes containing active and inactive forms of the G protein GαoPLoS ONE · 2025
10. Protofibril Binding Peptides Recognize and Inhibit Huntingtin Amyloid Formation in vitro and in vivo2025
11. ACE-031, a Soluble Activin Type IIB Receptor, Increases Muscle Mass and Strength in the Common Marmoset (Callithrix jacchus)2025
12. Preclinical assessment of pharmacokinetics and anticonvulsant activity of CBDTech, a novel orally administered cannabidiol (CBD) formulation for seizure and epilepsyJournal of Cannabis Research · 2025
13. Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A)Proceedings of the National Academy of Sciences · 2025
14. Deep Learning Model for Automated Classification of Macular Neovascularization Subtypes in AMDInvestigative Ophthalmology & Visual Science · 2025
15. Selective targeting of oncogenic KRAS G12D using peptide nucleic acid oligomers attached to cell-penetrating peptides2025
16. ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia VeraActa Haematologica · 2025
17. Efficacy and Safety of Zilucoplan in Amyotrophic Lateral SclerosisJAMA Network Open · 2025
18. Muscle-derived myostatin is a major endocrine driver of follicle-stimulating hormone synthesisScience · 2025
19. Population Pharmacokinetic/Pharmacodynamic and Exposure‐Response Modeling Analyses of Sotatercept in Healthy Participants and Patients with Pulmonary Arterial HypertensionClinical Pharmacology & Therapeutics · 2024
20. Expediting treatments in the 21st century: orphan drugs and accelerated approvalsOrphanet Journal of Rare Diseases · 2024